Archive for the ‘Pharma Industry’ Category
Monday, March 3rd, 2008
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Pfizer's chemotherapy agent, Camptosar(R) (Irinotecan Hydrochloride) Injection, 20 mg/mL. Shipment of this product, available in 40 mg/2 mL ...
Posted in Pharma Industry | No Comments »
Tuesday, February 26th, 2008
The CCA, AIMp, NPA, PSNC and RPSGB have provided a joint response to the Department of Children, Schools and Families consultation on the Safeguarding Vulnerable Groups legislation and the proposed scheme that will be administered by the Independent Safeguarding Authority (ISA). A joint response was prepared because of the wide ...
Posted in Pharma Industry | No Comments »
Tuesday, February 26th, 2008
Antisense Therapeutics Limited (ASX: ANP) announced that the Company is scheduled to present at Sachs Associates 7th Annual North America Forum for Investing and Partnering in Biotech taking place on February 25-26 in Boston at the Fairmont Copley Plaza.
Mark Diamond, Antisense Therapeutics Chief Executive Officer, will give a presentation on ...
Posted in Pharma Industry | No Comments »
Monday, February 25th, 2008
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced the receipt of a positive opinion from the CHMP, the scientific committee of the European Medicines Agency ("EMEA"), for its human granulocyte colony stimulating factor ("G-CSF") product. Teva's product is the first biosimilar G-CSF to receive a positive opinion in the European Union.
The ...
Posted in Pharma Industry | No Comments »
Monday, February 25th, 2008
The American Association of Colleges of Pharmacy (AACP) will recognize four student-led community engaged service projects that provide care to the underserved with the inaugural AACP Student Awards for Community Engaged Service.
Sponsored by Teva Pharmaceuticals, this annual award program will recognize a community-engaged service program developed and delivered by doctor ...
Posted in Pharma Industry | No Comments »
Friday, February 22nd, 2008
The prices of brand-name medications have continued to increase despite calls from all three major presidential candidates for pharmaceutical companies to make their products more affordable, the Wall Street Journal reports. Wholesale prices for the 50 brand-name medications with the most sales increased by an average of 7.82% in 2007, ...
Posted in Pharma Industry | No Comments »
Friday, February 22nd, 2008
The Biotechnology Industry Organization (BIO) and BIO Ventures for Global Health (BVGH) are pleased to announce U.S. Senator Sam Brownback, R-Kan., will deliver the Breakfast Plenary, "Incentives to Drive Innovation," at the Partnering for Global Health Forum 2008, to be held March 11-12 near Washington, D.C. The conference, which is ...
Posted in Pharma Industry | No Comments »
Friday, February 22nd, 2008
ASHP encouraged the National Quality Forum (NQF) to add platelet monitoring for low-molecular weight heparins to proposed quality measures for the prevention and treatment of venous thromboembolism in hospitalized patients.
The Society's recommendations are consistent with American College of Chest Physicians' guidelines calling for platelet monitoring every two or three days ...
Posted in Pharma Industry | No Comments »
Friday, February 22nd, 2008
The Wall Street Journal on Wednesday examined House Energy and Commerce Oversight and Investigations Subcommittee Chair Bark Stupak's (D-Mich.) efforts to increase FDA oversight and improve the safety of prescription drugs. According to the Journal, Stupak is "at the center of an aggressive effort by congressional Democrats to spotlight what ...
Posted in Pharma Industry | No Comments »
